Dr Reddy's Laboratories Shares Rallied As Much As 6 Percent In Morning

Dr Reddy's Laboratories shares rallied as much as 6 percent in morning Tuesday on getting clearance to Bachupally plant.

The pharma major informed exchanges that it has received an establishment inspection report from the US Food and Drug Administration on Monday after closure of audit of Bachupally unit, Hyderabad.

In April, the USFDA conducted an audit of this formulation manufacturing plant 3 and issued a form 483 with 11 observations.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory